All items in the Healthy Skepticism Library
All the 18635 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 185 of 187 pages « First < 183 184 185 186 187 >
HSL9051
Huxley A.
Brave New World
: Harper Collins 1931
http://www.harpercollins.com/books/9780060850524/Brave_New_World/index.aspx
HSL2041
Hopkins CC.
My Life in Advertising.
Chicago: 1996 reprint by NTC Business Books 1927
http://books.mcgraw-hill.com/getbook.php?isbn=0844231010&template=
HSL2042
Hopkins CC.
Scientific advertising.
Chicago: 1996 reprint by NTC Business Books 1923
http://books.mcgraw-hill.com/getbook.php?isbn=0844231010&template=
HSL9089
Wells HG
Tono-Bungay
New York: Dodd, Mead & Co 1908
http://www.amazon.com/Tono-Bungay-Modern-Library-Classics-Wells/dp/081296750X
HSL16717
Wolfe S
Patients for Sale?
The Washington Post 1897 Oct 4
HSL2052
Bentham J, Dumont P, Bingham P.
Bentham's handbook of political fallacies
Baltimore: John Hopkins Press 1824
http://www.amazon.com/exec/obidos/tg/detail/-/B0006S0DMG/qid=1124494775/sr=1-1/ref=sr_1_1/002-4340062-2313626?v=glance&s=books
HSL693
Locke J.
An essay concerning human understanding
1690
http://etext.library.adelaide.edu.au/l/locke/john/l81u/index.html
HSL692
Aristotle.
Rhetoric.
Date uncertain 350BCE
http://www.public.iastate.edu/~honeyl/Rhetoric/index.html
HSL1654
Errett B.
What does it do? Um ... ask your doctor
National Post Date uncertain 2002
HSL2235
Malugani M.
Want a Future in Pharmaceutical Sales?
http://healthcare.monster.com/pharm/articles/pharmsales/
HSL2677
Canadian Association of Retired Persons
C.A.R.P.’s position on the direct-to-consumer advertising of prescription drugs
Canadian Association of Retired Persons;
www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/consult/wkshd2ca.zip
HSL7031
GAO .
Prescription Drugs : Improvements needed in FDA's Oversight of Direct-to-Consumer Advertising
United States Government Accountability Office ( GAO) 2006 Nov 31
http://www.gao.gov/new.items/d0754.pdf
HSL7264
Toledano Mayoral G, Salmeron Garcia A, Roman Marquez E, Cabeza Barrera J.
[Inappropriate commercial presentation of selected drugs and associated overcost]
Farm Hosp. 2006 May-Jun;30:(3):195-6
http://www.grupoaran.com/mrmUpdate/lecturaPDFfromXML.asp?IdArt=458140&TO=RVN&Eng=0
HSL7265
Burgos A.
[Spanish code of good practice for medicinal drug promotion: a deontological supervision unit]
Farm Hosp.
2006 May-Jun;30(3):137-8 Spanish sh;
http://www.grupoaran.com/mrmUpdate/lecturaPDFfromXML.asp?IdArt=458130&TO=RVN&Eng=0http://
HSL7371
Tapley AL, Lurie P, Wolfe SM.
Suboptimum use of FDA drug advisory committees
Lancet. 2006 Dec 23;368:(9554):2210
http://www.citizen.org/publications/release.cfm?ID=7493
HSL7515
The art of mismanagement.
Nat Biotechnol. 2006 Nov;24:(11):1300
http://www.nature.com/nbt/journal/v24/n11/abs/nbt1106-1300a.html
HSL7519
Miles A, Loughlin M.
Continuing the evidence-based health care debate in 2006.
The progress and price of EBM Eval al;
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2006.00740.x
HSL7522
Pawlotsky JM.
Science, medicine and the markets.
J Hepatol 2006 Sep;45:(3):341-2
http://linkinghub.elsevier.com/retrieve/pii/S0168-8278(06)00340-0
HSL7549
Blackwell AE, Beck JM
Drug manufacturers' First Amendment right to advertise and promote their products for off-label use: Avoiding a pyrrhic victory
Food and Drug Law Journal 2003;58:(3):439-462
HSL7550
Evans GW, Friede AI
The Food and Drug Administration's regulation of prescription drug manufacturer speech: a First Amendment analysis.
Food Drug Law J. 2003;58:(3):365-437
HSL7555
Gibbs JN, Ferrari PL, Murphy AM;
Ripe for revision: Reassessing the constitutionality of Food and Drug Administration restrictions on protected speech
Food and Drug Law Journal 2003;58:(3):331-345
HSL7587
Dowden JS.
Product information past perfect
Med J Aust 2007;186:(2):51-52
http://www.mja.com.au/public/issues/186_02_150107/dow11056_fm.html
HSL7673
Vockley M.
Called to testify?
It's 90 percent preparation, 10 percent deposition Instrum ed;
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17190077&dopt=Abstract
HSL7749
Tieman J.
Drug-altered states - As pharmaceutical spending continues to soar, state legislatures are taking bold steps to rein in their costs
Modern Healthcare 2002;32:(17):28-31
HSL8049
Mathez P, Chapuis S.
[Blood transfusion and advertising]
Transfus Clin Biol.
2006 Sep;13(3):211-4 Epub 200;
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VN7-4KVXHWM-1&_user=10&_coverDate=09%2F30%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0393582c6798cca1a65f4bbb56743ad9
HSL8050
Mathez P, Chapuis S.
Blood transfusion and advertising
Transfus Clin Biol.
2006 Sep;13(3):211-4 Epub 200;
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VN7-4KVXHWM-1&_user=10&_coverDate=09%2F30%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0393582c6798cca1a65f4bbb56743ad9
HSL8137
McKechnie S.
Advertising by pharmaceutical companies in eBMJ.
BMJ 1999;318:(7183):598
http://www.bmj.com/cgi/content/full/318/7183/598
HSL8165
Pearson P, McWhinney P, Stanley P.
Resistance to antibiotics: Prescribing of antibiotics needs to be rational
British Medical Journal 1998 Nov;317:1521
http://www.bmj.com/cgi/content/full/317/7171/1521/b
HSL8170
Muse DN.
Medicaid's transition into managed care? Real or imaginary?
Pharmacoeconomics. 1998;14:(Suppl 1):57-67.
http://www.ncbi.nlm.nih.gov/pubmed/10186483
HSL8342
Cacciatore GG.
Advertising, computers, and pharmacy liability: A Michigan court's decision has ramifications for pharmaceutical care
Journal of the American Pharmaceutical Association 1996 11;36:651-654
HSL8345
Drug advertising: is this good medicine?
Consum Rep 1996 Jun;61:(6):62-3
HSL8428
Franz CE, Epstein R, Miller KN, Brown A, Song J, Feldman M, Franks P, Kelly-Reif S, Kravitz RL.
Caught in the act?
Prevalence, predictors, and consequences of physician detection of unannounced standardized patients Serv th;
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17116121&dopt=Abstract
HSL8523
Jureidini JN, Mansfield PR.
The scope of the problem of the relationship between drug companies and doctors
Maitra B, Timimi S. Critical Voices in Child and Adolescent Mental Health London: Free Association Books 2006
http://www.fabooks.com/book.php?id=434
HSL8559
Kunin CM.
Problem of antibiotic usage.
Definitions, causes, and proposed solutions Intern Int;
HSL8571
What you should know about the FTC
J Am Pharm Assoc. 1975 Dec;15:(12):668-77
HSL8829
Angell M.
The Truth About the Drug Companies: How They Deceive Us and What to Do About It
New York: Random House 2004
http://www.randomhouse.com/acmart/?view=about
HSL8845
Ellenhorn MJ.
Future shock: drug therapy and the US pharmaceutical industry
Journal of Clinical Pharmacology 1975 May-Jun;15:385-400
http://jcp.sagepub.com/cgi/reprint/15/5/385
HSL8923
Towse A.
The UK pharmaceutical market: An overview
PharmacoEconomics 1996;10:14-25
HSL8924
Le Pen C.
Drug pricing and reimbursement in France. Towards a new model?
Pharmacoeconomics. 1996;10:(Suppl 2):26-36.
http://www.ncbi.nlm.nih.gov/pubmed/10163433
HSL9203
Rozek RP.
Critique of the GAO report on differences in prices for prescription drugs between Canada and the United States
Journal of Research in Pharmaceutical Economics 1998 Mar;6:(1):77-91
HSL9370
Physicians say direct-to-consumer advertising affects patient behavior.
Am J Hosp Pharm. 1993 Jul;50:(7):1329
HSL9379
Clinton team works with drug companies to expand access, restrict costs.
Am J Hosp Pharm. 1993 Mar;50:(3):388, 391
HSL9387
Congress compromises on Medicaid drug pricing; 'best price' excludes VA, others.
Am J Hosp Pharm. 1993 Jan;50:(1):16, 19
HSL9393
FDA user fees approved.
Clin Pharm. 1993 Jan;12:(1):3
HSL9394
FDA proposes more stringent pediatric-use labeling of prescription drug products.
Clin Pharm. 1993 Jan;12:(1):6
HSL9417
Rubin R.
FDA whistle-blower shifts Arcoxia fight to Europe
USA Today -2007 -Apr -15
http://www.usatoday.com/news/health/2007-04-15-fda-arcoxia_N.htm
HSL9424
Cavara C.
Innovative products in the pharmaceutical field: Part 3
Bollettino Chimico Farmaceutico 1991 Nov;130:409-421
HSL9438
FDA issues import alert against unapproved mail-order drugs.
Am J Hosp Pharm. 1992 May;49:(5):1024
HSL9458
American Academy of Pediatrics Committee on Drugs: Prescription drug advertising direct to the consumer.
Pediatrics. 1991 Jul;88:(1):174-5
HSL9678
Bertoldi AD, Barros AJ, Hallal PC, Lima RC.
[Drug utilization in adults: prevalence and individuals determinants]
Rev Saude Publica. 2004 Apr;38:(2):228-38
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102004000200012&tlng=en&lng=en&nrm=iso
HSL9721
Peterson GM.
Risk factors - but only after excluding high-risk subjects
Pharmacoepidemiology and Drug Safety 2004;13:(4):253
http://www3.interscience.wiley.com/cgi-bin/abstract/106600330/ABSTRACT?SRETRY=0
HSL9722
Willy ME, Li Z.
What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling
Pharmacoepidemiology and Drug Safety 2004;13:(4):201-206
http://www3.interscience.wiley.com/cgi-bin/abstract/104530108/ABSTRACT
HSL9747
The truth is out there.
Lancet Neurol. 2003 May;2:(5):261
http://linkinghub.elsevier.com/retrieve/pii/S1474442203004010
HSL9794
Gonzalez Hernando S, Gonzalez Mieres C, Diaz Martin AM.
Intention of purchasing generic prescription drugs on the part of consumers in Asturias, Spain
Rev Esp Salud Publica. 2003 Nov;77:(6):691-9
HSL9891
Levy C, Bonastre J.
[The cost of chemotherapy]
Bull Cancer. 2003 Nov;90:(11):976-82
http://www.john-libbey-eurotext.fr/fr/revues/medecine/bdc/e-docs/00/03/FC/CE/resume.md
HSL9953
The statin wars: why AstraZeneca must retreat.
Lancet. 2003 Oct 25;362:(9393):1341
http://ezproxy.library.uq.edu.au/login?url=http://dx.doi.org/10.1016/S0140-6736(03)14669-7
HSL9955
Potter JE, Moore AM, Byrd TL.
Cross-border procurement of contraception: estimates from a postpartum survey in El Paso, Texas
CONTRACEPTION 2003;68:(4):281-7
http://linkinghub.elsevier.com/retrieve/pii/S001078240300177X
HSL10053
Zhang Y, Soumerai SB.
Do newer prescription drugs pay for themselves?
A reassessment of the evidence Aff th;
http://content.healthaffairs.org/cgi/content/full/26/3/880
HSL10374
Baele PL.
Miss-'n-mix and mimics Batch DM 998
Acta Anaesthesiologica Belgica 2003;54:(2):149-150
HSL10423
Seligman PJ.
'Dear doctor....' - Evaluating the impact of risk communication efforts
Pharmacoepidemiology and Drug Safety 2003;12:(4):291-293
HSL10432
New drugs: watch out for unexpected adverse effects.
Prescrire Int. 2002 Oct;11:(61):150-1
http://www.ncbi.nlm.nih.gov/pubmed/12378747
HSL10433
Selegiline: a second look.
Six years later: too risky in Parkinson's disease 2002;11:(60):108-111
HSL10508
Toop L, Richards D, Dowell T.
The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand; 'Possums in the headlights?'.
British Journal of General Practice 2003;53:(489):342-345
http://www.ingentaconnect.com/content/rcgp/bjgp/2003/00000053/00000489;jsessionid=1dei97cpjj6ai.henrietta?
HSL10807
Yang J.
Modern medicine environment and adaptation of Korean trader for medicinal herbs from the late 19th century to the early 20th century
Uisahak. 2006 Dec;15:(2):189-209
HSL10895
Copper BK.
Notes and comments 'High and dry?' The Public Readiness and Emergency Preparedness Act and liability protection for pharmaceutical manufacturers.
J Health Law 2007;40:(1):65-105
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17549932&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10896
Weigh risks, rewards of joint hospital-physician advertising.
Health Care Strateg Manage. 2007 May;25:(5):4-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17549904&dopt=Abstract
HSL10898
Jaquette I.
Merck KGaA v Integra Lifesciences I, Ltd: implications of the supreme court's decision for the people who matter most ...the consumer.
Am J Law Med 2007;33:(1):97-117
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17547356&dopt=Abstract
HSL11021
Bertele' V, Assisi A, Di Muzio V, Renzo D, Garattini S.
New antirheumatic drugs: any real added value? A critical overview of regulatory criteria for their marketing approval
Eur J Clin Pharmacol. 2007 July 24;Epub ahead of print:
http://www.springerlink.com/content/e574527x0733r135/
HSL11037
Wilson M.
Human Rights and the Failure of Research Governance
Journal of Disability Policy Studies Summer 2007;18:(1):57-59
http://www.ingentaconnect.com/content/proedcw/jdps/2007/00000018/00000001/art00006
HSL11089
[No authors listed].
Antidepressants and suicide.
The history of a controversy--and where it stands today Ment Me;
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17663067&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11127
Fisher MA.
Medicine and Industry: A Necessary but Conflicted Relationship
Perspect Biol Med. 2007 Winter;50:(1):1-6
http://muse.jhu.edu/login?uri=/journals/perspectives_in_biology_and_medicine/v050/50.1fisher.html
HSL11190
Croll TP, Swanson BZ Jr.
Dental trade cards XXII.
19th century dentistry advertising trade cards Hist st;
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17354677&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11714
Nordlund C.
Hormones for life?
Behind the rise and fall of a hormone remedy (Gonadex) against sterility in the Swedish welfare state Hist Hi;
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VHP-4N1SK1B-9&_user=10&_coverDate=03%2F31%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=66ff12289e4288675a601a29fec617d4
HSL12160
FDA and industry happenings.
J Interv Cardiol. 2007 Oct;20:(5):406-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1540-8183.2007.00288.x
HSL12203
Coleman MP.
Not credible: a subversion of science by the pharmaceutical industry: Commentary on a global comparison regarding patient access to cancer drugs
Ann Oncol 2007 Sep;18:(Suppl 3):175
http://annonc.oxfordjournals.org/cgi/content/full/18/9/1433
HSL12250
Bero L.
Shall we ban industrial funds for research?
Epidemiol Prev. 2007 Jul-Aug;31:(4):171-4
http://www.ncbi.nlm.nih.gov/pubmed/18019196
HSL12319
Dach C.
The Media's New Aesthetic: Why TV is About to Have a Major Mood Swing.
Adbusters
http://www.adbusters.org
HSL12352
Quintaneiro T.
[The Brazilian pharmaceutical market and the North American war effort].
Estud Hist. 2002;(29):141-64
HSL12376
Kosińska K, Brandys J.
[Potentially inappropriate drugs for geriatric patients].
Przegl Lek. 2007;64:(1):19-23
http://www.ncbi.nlm.nih.gov/pubmed/18183827?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL12385
Steinman MA, Baron RB.
Rebuttal: Is CME a drug-promotion tool?: YES
Can Fam Physician 2007 Nov;53:(11):1877-9
http://www.cfp.ca/cgi/content/full/53/11/1877
HSL12386
Marlow B.
Rebuttal: Is CME a drug-promotion tool?: NO
Can Fam Physician 2007 Nov;53:(11):1877-9
http://www.ncbi.nlm.nih.gov/pubmed/18000248
HSL12387
Macias W, Pashupati K, Lewis LS.
A wonderful life or diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television
BMC Med Educ. 2007 Oct 12;7:(36):
http://www.ncbi.nlm.nih.gov/pubmed/17967146
HSL12446
Montagne M.
Drugs on the internet. I: introduction and web sites on psychedelic drugs.
Subst Use Misuse. 2008;43:(1):17-25
http://www.informaworld.com/smpp/content?content=10.1080/10826080701690698
HSL12554
Time-Line for Forsyth v. Eli Lilly Trial
: Baum Headland
http://www.baumhedlundlaw.com/media/timeline.html
HSL12605
Tajanko E, Sein Anand J, Roszkowska-Kranc K, Kozłowska-Boszko B, Chodorowski Z, Korolkiewicz RP.
[Drug counterfeiting--the risk to the public health].
Przegl Lek. 2007;64:(4-5):357-9
http://www.ncbi.nlm.nih.gov/pubmed/17724913?dopt=Abstract
HSL12679
Martín-Aranda P, Vázquez I, Rodríguez de Cossío A.
[Interns and the pharmaceutical industry].
Aten Primaria. 2007 Sep;39:(9):510-1
http://www.doyma.es/cgi-bin/wdbcgi.exe/doyma/mrevista.fulltext?pident=13109506
HSL12710
Pharmacovigilance in Europe and patient safety: no to deregulation
HAI 2008 Feb
www.haiweb.org/15022008/PR_ConsultPharmacoVigJan08_En.pdf
HSL12721
Morgan S, Cunningham C.
The Effect of Evidence-Based Drug Coverage Policies on Pharmaceutical R&D: A Case Study from British Columbia
Longwoods Publishing 2008;
http://www.longwoods.com/product.php?productid=19524&page=1
HSL12748
Howland RH.
How are drugs approved? Part 1: the evolution of the Food and Drug Administration
J Psychosoc Nurs Ment Health Serv 2008 Jan;46:(1):15-9
http://www.ncbi.nlm.nih.gov/pubmed/18251347
HSL12786
Prescriptions for confusion: Some retailers have improved the pill bottle, but the written information that comes with medications is confusing.
Harv Health Lett. 2007 Oct;32:(12):1-2
http://www.ncbi.nlm.nih.gov/pubmed/18246620
HSL12849
Srivastava RK.
Personal effects? Can emotive marketing through relationships influence rational doctors' prescriptions
Mark Health Serv 2007;27:(4):29-32
http://www.ncbi.nlm.nih.gov/pubmed/18186452?dopt=Abstract
HSL12850
Pfizer warns health care professionals of possible carcinogen in Viracept.
AIDS Read 2007 Nov;17:(11):528
http://www.ncbi.nlm.nih.gov/pubmed/18167635?dopt=Abstract
HSL12853
Lopert R, Rosenbaum S.
What is fair? Choice, fairness, and transparency in access to prescription medicines in the United States and Australia
J Law Med Ethics 2007;35:(4):643-56, 512-3.
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1748-720X.2007.00187.x
HSL12856
Salas SP, Osorio F M, Vial C P, Rehbein V AM, Salas A C, Beca I JP.
[Conflicts of interest in clinical practice: Ethical analysis of some relationships with the pharmaceutical industry]
Rev Med Chil 2006 Dec;134:(12):1576-82.
http://www.scielo.cl/cgi-bin/fbpe/fbtext?pid=S0034-98872006001200014&lng=en&nrm=iso&tlng=en
HSL12859
Schwartsmann G, Picon PD.
When drugs are worth more than gold!
Lancet Oncol. 2007 Dec;8:(12):1049-50
http://www.thelancet.com/journals/lanonc/article/PIIS1470204507703534/fulltext
HSL12872
Siekmeier R, Lütz J, Wetzel D.
[Are test systems for diagnostics of infectious diseases safe? Experiences of the BfArM based on all notifications received until end of 2005]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2008 Feb;51:(2):221-34
http://www.springerlink.com/content/y8683g7084571486/
HSL12973
Stossel TP.
Has the hunt for conflicts of interest gone too far? Yes
BMJ 2008 March 1;336:(7642):467
http://www.bmj.com/cgi/content/full/336/7642/476?etoc
HSL13051
IMS Health Canada
Drug Treatment insights: Hormone Replacement Therapy
: IMS Health Canada 2006
http://www.imshealthcanada.com/vgn/images/portal/cit_40000873/6/1/79032750Insights01En061127.pdf
HSL13502
Rieger HJ.
[Advertising with pictorial portrayal of people in professional clothing. Decision of the Federal Court from March, 1, 2007].
Dtsch Med Wochenschr. 2008 April;133:(15):793
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2008-1075649
HSL13561
American College of Obstetricians and Gynecologists Committee on Ethics.
ACOG Committee Opinion No. 401: Relationships with industry
Obstet Gynecol. 2008 March;111:(3):799-804
http://www.greenjournal.org/cgi/reprint/111/3/799
Page 185 of 187 pages « First < 183 184 185 186 187 >
